The use of SGLT2 inhibitors to improve glycemic control has improved in recent years, but this newly published study from JAMA Network Open shows that some diabetes patients are not being offered this life-saving treatment.
In this featured study from the New England Journal of Medicine, British researchers share the results of a phase 2 trial for semaglutide in 230 patients with NASH.
SGLT-2 inhibitors are considered the drugs of choice for patients with very high or high cardiovascular risk with or without kidney disease.
Previous studies have shown that continuous subcutaneous insulin infusions can lead to improvements in clinical and quality of life benefits as compared to multiple daily injections of insulin. In this study, researchers led by Sanjeev Mehta, MD, MPH, of the Joslin Diabetes Center at Harvard University, test that concept in type 1 diabetes patients.
In-hospital deaths associated with diabetic ketoacidosis have been declining in recent years, but a new analysis shows that trend was reversed in 2020 due to COVID-19.
Study authors examined the risk of ED visits or hospitalizations for hypoglycemia among patients older than 65 who were initiated on glargine, detemir, or NPH insulin.
Investigators examined the relationship among obstructive sleep apnea, short sleep duration, and β -cell function in adults with overweight or obesity with prediabetes or recently diagnosed, treatment-naïve T2D.
Adopting an anti-inflammatory and low insulinemic diet of green leafy vegetables, full-fat dairy, wine, and coffee instead of red meat, processed meat, nonfatty fish, sugar-sweetened beverages, and refined grains, may reduce T2D risk in postmenopausal women.
Rheumatoid arthritis and osteoarthritis patients can experience poorly controlled severe type 2 diabetes, say French researchers who suggest considering targeting insulin resistance through treatment for joint and systemic inflammation.
Previous studies have shown that iron lowering therapy by phlebotomy can improve metabolic endpoints in cases of iron overload so, investigators writing in The Journal of Clinical Endocrinology and Metabolism, test this concept in women with hyperandrogenism.
